1
Various mediators and indicators of an inflammatory response are elevated in severely injured patients. 2, 3 Many of these factors are significantly higher in patients who eventually died compared with survivors.
1,4-6 Early or prolonged activation of the inflammatory response has been linked to the development of clinical syndromes, such as systemic inflammatory response syndrome, adult respiratory distress syndrome, and multiorgan system failure.
Polymorphonuclear leukocytes are an essential to the acute inflammatory response. A causal role for polymorphonuclear leukocytes in the lung injury associated with trauma and sepsis is widely accepted. [7] [8] [9] [10] [11] Their involvement in other forms of organ injury is supported by findings in animal models of disease. [12] [13] [14] [15] [16] [17] [18] The acute inflammatory response is carefully regulated through the interaction between a range of soluble and gel-phase mediators and the multiple cell types present in the area of injury. One hypothesis to explain remote organ injury following trauma is dysregulation of neutrophil function.
CXC chemokines are key mediators of neutrophil proinflammatory functions. Interleukin (IL) 8, the best studied, is produced in response to several inflammatory stimuli, including microbial products such as lipopolysaccharide and zymosan and the cytokines tumor necrosis factor ␣ (TNF-␣) and IL-1. It is secreted from monocytes, endothelial cells, fibroblasts, keratinocytes, and neutrophils. Interleukin 8 induces migration, activation, and sometimes proliferation of myeloid, lymphoid, and endothelial cells, melanocytes, and keratinocytes. In neutrophils, IL-8 induces calcium mobilization, priming of the respiratory burst, degranulation, and cytoskeleton reorganization in addition to cell migration.
Interleukin 8 binds to 2 receptors on the cell surface, CXCR-1 and CXCR-2, which are G proteincoupled 7-transmembrane domain receptors. Both receptors bind IL-8 and granulocyte chemotactic protein 2, with high affinity. However, CXCR-2 is considered a promiscuous receptor because it also binds growthrelated oncogene ␣ (GRO-␣), neutrophil-activating protein 2, and epithelial neutrophil activator 78. CXCR-1 and CXCR-2 ligation stimulates phosphoinositol hydrolysis, intracellular calcium mobilization, chemotaxis, and exocytosis, but only CXCR-1 stimulation results in activation of phospholipase D and the respiratory burst. The
PATIENTS, MATERIALS, AND METHODS

PATIENT SELECTION CRITERIA
Patients who had undergone trauma were studied within 24 hours of admission to the hospital. This point after injury was chosen to allow for resuscitation, medical or surgical interventions, and stabilization of the patient before neutrophil isolation. All patients with head injuries were excluded due to possible association of disseminated intravascular coagulopathy, which may have deleterious effects on neutrophil function. Pregnant patients were not encountered during this study period. Patients who received multiple transfusions were also included in this study. A wide range of Injury Severity Score (ISS) criteria were used so we could elucidate if the severity of injury affected the loss of receptor expression and function. This study was reviewed and approved by the Institutional Review Board at the University of Cincinnati, Cincinnati, Ohio.
PERIPHERAL BLOOD NEUTROPHIL ISOLATION AND PRETREATMENT WITH TNF-␣
After obtaining verbal informed consent from patients and healthy volunteers, venous blood was drawn in syringes containing 15% EDTA (Sigma-Aldrich Corp, St Louis, Mo). Erythrocytes were removed by dextran T-500 (Pharmacia, Piscataway, NJ) sedimentation. The leukocyte-rich supernatant was layered over Ficoll-hypaque (Histopaque 1077; Sigma-Aldrich Corp) and centrifuged at 400g for 30 minutes at 4°C. Pelleted neutrophils were resuspended in phosphate-buffered saline without calcium or magnesium (Gibco, Grand Island, NY), and residual erythrocytes were removed by hypotonic lysis. Neutrophil preparations were routinely greater than 95% pure, with greater than 95% viability by trypan blue exclusion.
FLOW CYTOMETRY
Two million freshly isolated neutrophils were resuspended in phosphate-buffered saline containing 2% goat serum (Gibco) and incubated with 1 µg of either monoclonal mouse anti-human CXCR-1 or CXCR-2 antibodies or isotype control antibodies (Pharmingen, San Diego, Calif) for 20 minutes at 4°C. The monoclonal antibodies bind to the amino termini of the receptors. Specifically, the anti-CXCR-1 antibody binds to amino acids 2 to 14 of CXCR-1, while the anti-CXCR-2 antibody binds to amino acids 1 to 14 of CXCR-2. Neither antibody competes for IL-8 receptor binding. 22 Interleukin 8 does not compete with either antibody for receptor binding. 23, 24 The cells were washed with phosphate-buffered saline containing 2% goat serum and then incubated with 1 µg of fluorescently labeled goat anti-mouse immunoglobulin (Kirkegaard and Perry Labs, Gaithersbury, Md) for 20 minutes at 4°C. After 2 final washes, cells were resuspended in 1% paraformaldehyde and analyzed on a flow cytometer (model Epics XL; Coulter, Miami, Fla). Flow cytometry readings were performed after standardization with beads (Standard-Brite; Coulter).
BOYDEN CHAMBER CHEMOTAXIS
The lower wells of the modified Boyden chamber were filled with various stimulants, including IL-8 (R&D, Minneapolis, Minn), fMLP (Calbiochem, San Diego, Calif ), leukotriene B 4 (Sigma-Aldrich Corp), and GRO-␣ (R&D). A 5-µm-pore nitrocellulose filter (Neuroprobe, Cabin John, Md) was placed over the stimulants, followed by a gasket and the upper half of the chamber. Freshly isolated neutrophils (1 ϫ 10 5 ) were loaded into each well. The chamber was incubated at 37°C, with 5% carbon dioxide, for 30 minutes. The nitrocellulose filter was removed, fixed with 2.5% glutaraldehyde, and stained with hematoxylin. The filter was sequentially dried in 70% ethanol, 95% ethanol, and a combination of ethanol-butanol (80: 20) , and cleared using xylene. It was then mounted on a 50 ϫ 75-mm slide. The distance migrated by the leading front of cells was determined using a light microscope with a calibrated knob.
CALCIUM MOBILIZATION EXPERIMENTS
Polymorphonuclear leukocytes were incubated with a calcium chelator, 1 µmol/L (Fura-2/AM; Molecular Probes, Eugene, Ore), for 45 minutes at 37°C. The cells (2.5 ϫ 10 6 ) were then washed and resuspended in Hanks balanced salt solution with calcium; magnesium; HEPES, 20 mmol/L; and 0.1% bovine serum albumin at pH 7.4. The baseline calcium concentration was 1.26 mmol/L. Fluorescence was measured on a spectrofluorometer (PTI, South Brunswick, NJ), with an excitation wavelength of 340 nm and an emission wavelength of 510 nm at 37°C, following stimulation with chemokines.
MATHEMATICAL CALCULATIONS AND STATISTICAL ANALYSIS
In flow cytometry experiments, results were expressed as a percentage of mean channel fluorescence of patient cells vs normal cells. In chemotaxis experiments, the distance migrated by patient cells to buffer was subtracted from the distance migrated to IL-8, GRO-␣, or fMLP. The percentage migration was calculated dividing the net distance migrated by patient cells by the net distance migrated by normal cells. Flow cytometry and chemotaxis results represent the mean ± SE values. Flow cytometry data were analyzed using the unpaired t test, and chemotaxis data were analyzed using analysis of variance (Prism; Graft Pad Software, San Diego, Calif ).
receptors also vary in the way their expression and function are regulated. In vitro studies [19] [20] [21] have shown preferential loss of CXCR-2 receptor expression and function after exposure to various stimulants, including IL-8, GRO-␣, N-formyl-methionyl-leucyl-phenylalanine (fMLP), C5a, and TNF-␣.
We have recently generated data supporting the notion that CXCR-2 is a regulatory receptor. This model proposes that CXCR-2 ligation primarily serves to modify neutrophil responses in a chemokine-specific manner. For example, CXCR-2-specific ligand GRO-␣ suppresses TNF-␣ adherence-dependent peroxide production, while neutrophil-activating protein 2 inhibits IL-8-stimulated chemotaxis. The expression and functional status of these receptors in trauma has not been previously studied, and provided an opportunity to test our in vitro findings in an in vivo human disease state. In this study, we show that patients who have undergone trauma have a severity-dependent and preferential loss of CXCR-2 expression and function. We speculate that this loss of CXCR-2 function might be permissive in the immigration and toxic functioning of neutrophils in traumatized persons.
RESULTS
Study participants included 12 men and 8 women; the mean ± SD age of the participants was 35 ± 14 years (range, 18-51 years). The ISSs ranged from 1 to 50 (mean ± SD, 19 ± 15); 19 injuries sustained were blunt, while 1 was penetrating; and there were no deaths. The mean ± SD white blood cell count of the patients was 14.0 ± 5.0 ϫ 10 9 /L (range, 6.8-24.0 ϫ 10 9 /L). Patients were grouped by severity of injury based on the survival curves demonstrated by Champion, Sacco, and Copes: group 1, ISS of 8 or less; group 2, ISS of 9 through 15; and group 3, ISS of 16 or greater. 21 The severely injured patients are a single group because mortality increases with ISSs greater than 16, and we wanted to determine if there was a difference between the mildly, moderately, and severely injured patients.
FLOW CYTOMETRY
To investigate changes in cell surface CXC receptor expression, we used flow cytometry analysis (Figure 1 ). There was a significant loss of CXCR-2 in the severely injured group compared with the mildly (PϽ.001) and the moderately (P = .05) injured groups. Loss of CXCR-1 was not statistically significantly different between the groups.
CHEMOTAXIS
To assess if functional loss was concordant with loss of receptor expression, migration to 10 nmol of IL-8, GRO-␣, and fMLP was measured (Figure 2) . With all stimulants, there appeared to be a trend toward loss of chemotaxis as injury severity increased. There were no differences between stimulants or between patient groups. Loss of chemotaxis was broadly effected.
CALCIUM MOBILIZATION
After determining that there was an appreciable decrease of receptor expression and function in the severely injured patients, we decided to determine if receptor-signaling effector coupling had been altered. We used calcium mobilization to study changes in receptor signaling ability. Stimulation of patient neutrophils with 10 nmol of IL-8 or fMLP showed no difference in their ability to mobilize calcium between the injury groups (Figure 3) . Patients who had ISSs greater than 16 lost the ability to mobilize calcium to the CXCR-2-specific chemokine GRO-␣. There were no differences in total calcium cellular content as demonstrated by lysis with 10% Triton X-100 after chemokine stimulation. ARCH SURG/ VOL 134, DEC 1999 As such, the regulation of these receptors is important for determining the character of the inflammatory response. Given the complex cytokine, complement, and lipid mediator fields these cells encounter, it is possible that dysregulation of neutrophil functions relates to cell exposure to 1 or more of these molecules. We have previously shown that CXCR-2 may play a role in the regulation of certain neutrophil functions, particularly IL-8 suppression of IL-8-induced chemotaxis by neutrophilactivating protein 2 and suppression of TNF-␣-induced oxidative burst by GRO-␣. 18 Loss of this regulation may cause increased cell migration and production of destructive oxygen radicals. This may contribute to comorbid pathological characteristics, such as adult respiratory distress syndrome, systemic inflammatory response syndrome, or multiorgan system failure, observed in severely injured patients.
In this study, we showed that cell surface expression of CXCR-1 and CXCR-2 is decreased following traumatic injury. Loss of CXCR-2 is greater than loss of CXCR-1, particularly in the severely injured group of patients. In the severely injured patient, neutrophils are likely exposed to cytokines for prolonged periods, which may in turn contribute to the increased loss of the receptor on the cell surface. These data are consistent with previous studies 25, 26 that showed that CXCR-2 is internalized more rapidly than CXCR-1 and that expression of CXCR-2 recovers more slowly than CXCR-1 after exposure to various cytokines. Like other G protein-coupled receptors, CXCR-2 is phosphorylated on C terminal serine residues. Phosphorylation targets the receptor for internalization and degradation, and renders it incapable of interacting with G proteins needed for signal transduction.
Our data show a specific loss of a calcium flux response to GRO-␣ (a CXCR-2-specific ligand) in the moderately and severely injured patient groups. In contrast, calcium mobilization to IL-8 and fMLP is preserved in all patient groups. It would appear that not only is CXCR-2 removed from the surface but that the remaining CXCR-2 receptors are desensitized, possibly by phosphorylation, and are therefore unable to transduce a binding signal in contrast to CXCR-1 and fMLP receptors. This suggests that of the 3 receptors, only CXCR-2 is desensitized at the level of the receptor.
The loss of chemotaxis to fMLP and IL-8, as well as GRO-␣, suggests that a common chemotaxis signaling pathway is disrupted in these patients. Thus, there appears to be multiple points for regulating signaling by chemoattractant receptors. Some are proximal events as with CXCR-2, whereas other points are more distal as with the CXCR-1 and fMLP receptors. Massive transfusions may also have an impact on the expression and function of these receptors, but the probabilities are beyond the scope of this article. 15 While the relation of CXC receptor expression and function to trauma-induced inflammatory disease remains obscure, the study reported herein documents the selective loss of CXCR-2 expression and function in severely injured patients. Having previously documented CXCR-2-mediated suppression of oxidant production and inhibition of chemotaxis, we surmise that CXCR-2 may function as a regulator of the inflammatory response. Thus, specific loss of CXCR-2 expression and function may result in dysregulated cell function and thereby contribute to tissue injury at remote organ sites, leading to severe inflammatory syndromes and sepsis in patients who have suffered trauma. 
Statement of Clinical Relevance
Inflammatory syndromes, such as adult respiratory distress syndrome, systemic inflammatory response syndrome, and multiorgan system failure, are causes of morbidity and mortality in patients with trauma and burns who have otherwise survivable injuries. An important step in the evolution of these inflammatory disorders is the recruitment of neutrophils into the interstitium and the subsequent generation of oxidants, resulting in extracellular matrix destruction and cytotoxicity. A family of proteins termed chemokines induces neutrophil recruitment. CXC chemokines may also be involved in the regulation of the respiratory burst. Based on in vitro studies, we hypothesized that the exuberant inflammatory response could be due to a loss of the CXCR-2 receptor in patients who had undergone trauma and who had various ISSs. The study reveals that indeed there is a loss of CXCR-2 in peripheral neutrophils of severely injured patients, and the regulation of this receptor is proximal to calcium mobilization. We also found a loss of chemotaxis to all stimuli with a minimal concomitant loss of receptor on the cell surface, suggesting receptor desensitization. This loss of CXCR-2 may explain the up-regulation of the neutrophils' respiratory burst, which may lead to end organ damage such as seen in the aforementioned inflammatory syndromes. A more refined understanding of the mechanisms for these events will provide insight into potential therapeutic strategies.
ARCH SURG/ VOL 134, DEC 1999DISCUSSION Carol L. Miller Graziano, MD, Worcester, Mass: What has been really shown is that looking at a fairly novel chemokine and an important marker of potential PMN [polymorphonuclear leukocyte] alterations, the levels of the CXC chemotactic receptors on PMNs correlate to PMN numbers as well as to PMN functions. They have shown that there is a decrease in the detectable levels of CXCR-2 on the PMNs and that this is correlated with an increasing severity of injury.
One of the questions that I think is raised by these data is that since there are differences between IL [interleukin] 8 and GRO [growth-related oncogene], and 1 of those differences is that IL-8 has a very much higher affinity for binding to receptor, some of these data may be explained by the fact that IL-8 can compete off any ligand that is already bound onto the surface of the PMN, whereas GRO cannot, and consequently if you have ligand bound onto, that is, a chemokine, bound onto the receptor, the CXC receptor, you might not be able to see that being competed off with GRO, and so this would explain some of the data.
And I think this is particularly important, because there is actually a chemotactic defect to all the receptors, that is, IL-8, fMetPhe [formylmethionine-phenylalanine], and GRO all show a decrease in chemotactic stimulatory ability in the severely injured group. So that those differences cannot be explained just on the basis of the CXCR-2 binding. So one of the things I would like to ask is, have you looked at the internalization of this receptor, and that is, have you looked in a permeablized cell for internalization of the receptor? And the second thing is, have you looked molecularly or morphologically for differences in the actin mobilization? That might explain the chemokine differences as well as the chemotactic differences.
Dr Quaid: To address your first question, we are in the process of developing techniques to examine the internalization of events of the CXC receptors, specifically Western blot analysis and confocal microscopy. Localization of the receptor has not been done in patients to date.
We have not addressed the molecular or morphological changes to actin in association with these receptors.
Daniel T. Traber, MD, Galveston, Tex: In looking at peripheral circulating polymorphonuclear cells, you are just looking at the tip of an iceberg, and I would predict that in the trauma patients you would have IL-8 released, and the cells that had the most sensitive of the receptors would be moving out to lodge in the tissues where the IL-8 was released, and those would be replaced by more immature types of cells.
Have you looked at the number of receptors on these cells with regard to their age? New band cells, for instance, do they have a lower number of these receptors than an older polymorphonuclear cell?
Dr Quaid: We have not addressed that question to date, but it is a very good question. I think it is something we will consider in the future.
John A. Mannick, MD, Boston, Mass: About 13 or 14 years ago, I have forgotten which, our group, in association with Drs
